The interplay between bone and heart health as reflected in medication effects: A narrative review

There is mounting evidence of an association between osteoporosis and cardiovascular disease that extends beyond shared risk factors for these conditions. In turn, the medications used to treat each of these conditions can have effects that impact the other organ system: medications used in heart di...

Full description

Saved in:
Bibliographic Details
Published in:Women's Health 2023-01, Vol.19, p.17455057231165549-17455057231165549
Main Authors: Trost, Susanne, Tesfaye, Nolawit, Harindhanavudhi, Tasma
Format: Article
Language:English
Subjects:
Aldosterone
Angiotensin
Bone Density
Bone diseases
Bone mineral density
Calcium channel blockers
Calcium channels
Cardiovascular and Metabolic Bone Health in Aging Women
Cardiovascular disease
Cardiovascular diseases
Clinical trials
Diuretics
Heart
Heart diseases
Heart Diseases - chemically induced
Heart Diseases - complications
Heart Diseases - drug therapy
Humans
Metformin
Osteoporosis
Osteoporosis - chemically induced
Osteoporosis - drug therapy
Renin
Risk factors
Risk sharing
Sodium Chloride Symporter Inhibitors - adverse effects
Sodium-glucose cotransporter
Statins
Vitamin D
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is mounting evidence of an association between osteoporosis and cardiovascular disease that extends beyond shared risk factors for these conditions. In turn, the medications used to treat each of these conditions can have effects that impact the other organ system: medications used in heart disease have the potential to affect bone health, while osteoporosis medications may modify cardiovascular health. While data in this subject area are limited by the paucity of large randomized controlled trials with bone mineral density or fracture risk as primary outcomes, this review explores the data available that can provide some insight into these reciprocal effects of medications on bone and heart health. Data on bone health effects of the loop and thiazide diuretics, beta blockers, calcium channel blockers, statins, warfarin, sodium-glucose cotransporter 2 inhibitors, metformin, and medications impacting the renin–angiotensin–aldosterone system are examined; the cardiovascular effects of osteoporosis therapies and vitamin D are also discussed. Importantly, while most data in this realm are inconclusive, recognizing the parallels between cardiovascular and bone disorders and how this is reflected in medication effects might prompt the clinician to consider the indirect impact of drug regimens when making therapeutic choices for patients with osteoporosis and heart disease.
ISSN:1745-5057
1745-5065
DOI:10.1177/17455057231165549